Four pharma companies chimed in among the 146 official comments on the federal government’s plan to tag pharma TV ads with drug prices. Pfizer, Eli Lilly, Sanofi and Johnson & Johnson filed commentary, along with the industry’s leading trade association,
Endo International and the U.S. Federal Trade Commission (FTC) filed a joint motion in the U.S. District Court for the Northern District of California seeking the entry of a ten-year Stipulated Order for Permanent Injunction.